Skip to main content

Research Repository

Advanced Search

A case report of heterozygous familial hypercholesterolaemia with LDLR gene mutation complicated by premature coronary artery disease detected in primary care

Abdul-Halim, Mohamad Abu Zar; Abdul-Hamid, Hasidah; Baharudin, Noorhida; Mohamed-Yassin, Mohamed-Syarif; Kasim, Sazzli Shahlan; Nawawi, Hapizah; Qureshi, Nadeem; Ramli, Anis Safura

A case report of heterozygous familial hypercholesterolaemia with LDLR gene mutation complicated by premature coronary artery disease detected in primary care Thumbnail


Authors

Mohamad Abu Zar Abdul-Halim

Hasidah Abdul-Hamid

Noorhida Baharudin

Mohamed-Syarif Mohamed-Yassin

Sazzli Shahlan Kasim

Hapizah Nawawi

Anis Safura Ramli



Contributors

David Oxborough
Editor

Maya S Safarova
Editor

Abstract

Background: Familial hypercholesterolaemia (FH) is an autosomal dominant genetic condition predominantly caused by the low-density lipoprotein receptor (LDLR) gene mutation. Case summary: This is the case of a 54-year-old Malay woman with genetically confirmed FH complicated by premature coronary artery disease (PCAD). She was clinically diagnosed in primary care at 52 years old, fulfilling the Simon Broome Criteria (possible FH), Dutch Lipid Clinic Criteria (score of 8: probable FH), and Familial Hypercholesterolaemia Case Ascertainment Tool (relative risk score of 9.51). Subsequently, she was confirmed to have a heterozygous LDLR c.190+4A>T intron 2 pathogenic variant at the age of 53 years. She was known to have hypercholesterolaemia and was treated with statin since the age of 25. However, the lipid-lowering agent was not intensified to achieve the recommended treatment target. The delayed FH diagnosis has caused this patient to have PCAD and percutaneous coronary intervention (PCI) at the age of 29 years and a second PCI at the age of 49 years. She also has a very strong family history of hypercholesterolaemia and PCAD, where seven out of eight of her siblings were affected. Despite this, FH was not diagnosed early, and cascade screening of family members was not conducted, resulting in a missed opportunity to prevent PCAD. Discussion: Familial hypercholesterolaemia can be clinically diagnosed in primary care to identify those who may require genetic testing. Multidisciplinary care focuses on improving identification, cascade screening, and management of FH, which is vital to improving prognosis and ultimately preventing PCAD.

Journal Article Type Article
Acceptance Date Jan 19, 2024
Online Publication Date Jan 29, 2024
Publication Date Feb 1, 2024
Deposit Date Feb 7, 2024
Publicly Available Date Feb 7, 2024
Journal European Heart Journal - Case Reports
Print ISSN 2514-2119
Electronic ISSN 2514-2119
Publisher Oxford University Press
Peer Reviewed Peer Reviewed
Volume 8
Issue 2
Article Number ytae039
DOI https://doi.org/10.1093/ehjcr/ytae039
Keywords Multidisciplinary management, Premature coronary artery disease, Case report, Primary care, LDLR gene mutation, Heterozygous, Familial hypercholesterolaemia
Public URL https://nottingham-repository.worktribe.com/output/30667637
Publisher URL https://academic.oup.com/ehjcr/advance-article/doi/10.1093/ehjcr/ytae039/7590967
Additional Information © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com